The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Dragonfly Therapeutics, Inc. Appoints Dr. Susan Altschuller As Chief Financial Officer
PRIVATEAug 05, 2024•almost 2 years ago
Position
Chief Financial Officer
Company
Dragonfly Therapeutics, Inc.
Susan Altschuller
WalthamHealthcare
Description
Dragonfly Therapeutics, Inc. has expanded its executive leadership team with the addition of Dr. Susan Altschuller as Chief Financial Officer
Company Information
Company
Dragonfly Therapeutics, Inc.
Location
9800 PYRAMID COURT
Waltham, Massachusetts, United States
About
Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel technology to harness the body's immune system to bring breakthrough treatments to patients. Dragonfly has a deep pipeline of wholly-owned clinical and preclinical candidates discovered using its proprietary platform that are progressing toward the clinic, as well as productive collaborations with Bristol Myers Squibb, Merck and AbbVie across a broad range of disease areas. For more information visit us at www.Dragonflytx.com, or follow us on Linkedln and Twitter.